Author who lost $2M book deal over AI concerns claims allegations are racially motivatedAugust 4, 2026
The Startup Behind The Pill For Sleep Apnea Raises $192 Million In IPO News July 30, 2026 Even before it gets approval for its sleep apnea pill, Apnimed is testing investor appetite.The Cambridge, Mass.-based biotech priced its…
Inside Incyte’s $120 Million AI For Drug Development Deal Tech May 20, 2026 In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea,…